These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 15716832)

  • 1. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders.
    Kaneyama K; Segami N; Nishimura M; Suzuki T; Sato J
    Br J Oral Maxillofac Surg; 2002 Oct; 40(5):418-23. PubMed ID: 12379189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery.
    Krohn CD; Reikerås O; Aasen AO
    Eur J Surg; 1999 Feb; 165(2):101-9. PubMed ID: 10192566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of soluble cytokine factors in temporomandibular joint effusions seen on magnetic resonance images.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):411-8. PubMed ID: 15772591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders.
    Tominaga K; Habu M; Sukedai M; Hirota Y; Takahashi T; Fukuda J
    Arch Oral Biol; 2004 Jun; 49(6):493-9. PubMed ID: 15099807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis.
    De Benedetti F; Pignatti P; Gerloni V; Massa M; Sartirana P; Caporali R; Montecucco CM; Corti A; Fantini F; Martini A
    J Rheumatol; 1997 Jul; 24(7):1403-9. PubMed ID: 9228145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
    Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
    Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP; Kuzański W; Andrzejewska E
    Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
    Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
    Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of synovial tumor necrosis factor alpha and interleukin 6 to temporomandibular disorder.
    Lee JK; Cho YS; Song SI
    J Oral Maxillofac Surg; 2010 May; 68(5):1064-8. PubMed ID: 20031289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble receptors and cytokine antagonists in human milk.
    Buescher ES; Malinowska I
    Pediatr Res; 1996 Dec; 40(6):839-44. PubMed ID: 8947960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
    Chabaud M; Miossec P
    Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid.
    Partsch G; Steiner G; Leeb BF; Dunky A; Bröll H; Smolen JS
    J Rheumatol; 1997 Mar; 24(3):518-23. PubMed ID: 9058659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine balance in the lungs of patients with acute respiratory distress syndrome.
    Park WY; Goodman RB; Steinberg KP; Ruzinski JT; Radella F; Park DR; Pugin J; Skerrett SJ; Hudson LD; Martin TR
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1896-903. PubMed ID: 11734443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.